PYSZCZYMUKA GREG 4
4 · Evoke Pharma Inc · Filed Feb 24, 2025
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
PYSZCZYMUKA GREG
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-02-20+5,833→ 5,833 totalExercise: $5.26Exp: 2035-02-19→ Common Stock (5,833 underlying)
Footnotes (1)
- [F1]1/3rd of the total number of shares of common stock subject to the option shall vest following each one-year period after February 20, 2025, the date of grant, subject to the Reporting Person's continuous service to the Issuer through each vesting date, so that the option shall be fully vested on the third anniversary of the date of grant.